期刊文献+

凋亡指数在不同宫颈病变组织中的表达及其预测新辅助化疗疗效的作用

Expression of AI in the normal cervical tissue,CIN and cervical squamous carcinoma and their significance
下载PDF
导出
摘要 目的:探讨正常宫颈组织、CIN组织及化疗前后宫颈鳞癌组织凋亡指数(apoptosis index,AI)的表达及临床意义。方法:选取11例正常宫颈组织,23例宫颈病变CIN组织,30例宫颈鳞癌组织,应用TUNEL法检测组织AI。结果:化疗临床有效率为80%;正常宫颈组织、CIN组织及化疗前宫颈鳞癌组织中的AI分别为2.55±0.64、14.00±3.16和7.13±1.27(F=127.659,P<0.05),差异有统计学意义;化疗前后宫颈鳞癌组织AI分别为7.13±1.27和17.88±4.39(t=-1.736,P<0.05),差异有统计学意义;化疗前后有效组和无效组宫颈鳞癌组织AI变化值分别为12.21±4.38和4.95±2.69(t=3.849,P<0.05),差异有统计学意义。结论:新辅助化疗能诱导宫颈鳞癌细胞凋亡,AI增高预示疗效较好。 Objective: to study the expression of AI in the normal cervical tissue, CIN and cervical squamous carcinoma and their clinical significance. Methods: From 11 cases of normal cervical tissues, 23 cases of CIN and 30 cases of cervical eancer, AI was assayed by TdT-mediated dUTP-biotin nick end labeling(TUNEL). Results: Clinical response was 80% (24/30). The expression of AI were (2.55 ±0.64) in normal cervical tissues , ( 14.00±3.16) in CIN and (7.13 ±1. 27 ) in cervical cancer. The difercnce was significant. The mean AI after NACT was significantly higher in effective cases( P 〈 0.05). Conclusion: NACT could increase apoptosis of tumor cell in cervical squamous carcinoma tissue. The change of AI may be one of molecule mec, hanisms leading to anti-tumor function of NACT.
出处 《农垦医学》 2009年第2期123-125,共3页 Journal of Nongken Medicine
基金 新疆兵团科技攻关计划医药卫生专项基金资助项目(2006GG50)
关键词 宫颈组织 凋亡指数 新辅助化疗 cervical tissue apoptosis index, AI neoadjuvant chemotherapy, NACT
  • 相关文献

参考文献10

  • 1Fujiwara K.Antitumor effects and clinical problems of transcatheter Intraarterial infusion for uterine cervical cancer[J].GanTo Kagaku Ryoho,2006,33(9):1236-1240.
  • 2Nagata Y,Araki N,Kimura H,et a1.Neoadjuvant chemotherapy by transcatheter arterial infusion methed for uterine cervical cancer[J].J Vascerv Radiol,2000,11(3):313-319.
  • 3陈继明,王英红,郭晓青.宫颈癌动脉介入新辅助化疗近期疗效分析[J].农垦医学,2007,29(1):27-29. 被引量:5
  • 4Di Vagno G,Cormio G,Pignata S,et al.Cisplatin and vinorelbine as neoadjuvant chemotherapy in locally advanced cervical cancer:a phase II study[J].Int J Gynecol Cancer,2003,13(3):308-312.
  • 5曹泽毅.子宫颈癌治疗的变迁和思考[J].现代妇产科进展,2005,14(1):1-5. 被引量:26
  • 6Schulze-Bergkamen H,Krammer P H.Apoptosis in cancer implications for therapy[J].Semin Oncol,2004,31(1):90-119.
  • 7Levine E L;Renehan A,Gossiel R,et al.Apoptosis,intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma[J].Radiother oncol,1995,37(1):1-9.
  • 8Sushma M.Bhosle M S,Nagraj G,et al.Apoptotic index as predictive marker for radiosensitivity of cervical carcinoma:Evaluation of membrane fluidity,biochemical parameters and apoptosis after the first dose of fractionated radiotherapy to patients[J].Cancer Detection and Prevention,2005,29:369-375.
  • 9Lera J,Lara P C,Perez S,et al.Tumor proliferation P53 expression,and apoptosis in Laryngeal carcinoma[J].Cancer,1998,83(12):2493-2501.
  • 10Ho CM,Chien TY,Huang SH,et al.Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy[J].Gynecol Oncol,2004,93(2):458-464.

二级参考文献4

  • 1Benedetti-Panici P,Geogi S,Colombo A,et al.Neoadjuvant intraarterial chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer:results from the Italian multicenter randomized study.J Clin Oncol,2002,20(1):179~ 188
  • 2Kager L,Zoubek A,Kastner U,et al.Skip metastases in osteosarcoma:experience of the Cooperative Osteosarcoma Study Group.J Clin Oncol,2006,24(10):1535 ~ 1541
  • 3Fayette J,Blay JY.Adjuvant chemotherapy in the treatment of sarcomas.Bull Cancer,2006,93(3):257 ~ 261
  • 4Chen CA,Cheng WF,Wei LH,et al.Radical hysterectomy alone or combined with Neoadjuvant chemotherapy in the treatment of early stage bulky cervical carcinoma.J Formos Med Assoc,2002,101 (3):195 ~ 202]

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部